A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients
- 520 Downloads
Some bacterial species recovered from the airways of cystic fibrosis (CF) patients are indisputably associated with lung infections, whereas the clinical relevance of others, such as Nocardia spp., remains unclear. Sixteen French CF cases of colonization/infection with Nocardia spp. were reviewed in order to evaluate the epidemiology, the clinical impact and the potential treatment of these bacteria, and results were compared to those of the literature. Five Nocardia species were identified, Nocardia cyriacigeorgica being the major species (50 % of cases). At first isolation, Nocardia was the sole pathogen recovered in six patients. Seven patients presented pulmonary exacerbation. For 12 patients, antimicrobial treatment against Nocardia was started immediately, mainly based on cotrimoxazole (6 of the 12 cases). In this study, we highlight the heterogeneity of the clinical management of Nocardia spp. in CF. Guidelines for the clinical management of Nocardia infections in CF patients are proposed.
KeywordsNocardia Cystic fibrosis Lung infections Antimicrobial therapy Guidelines
The authors would like to thank Margaux Burguière for her help in collecting data from the CF Center of the University Hospital of Montpellier and the technician team of the different microbiological laboratories (Lyon, Montpellier and Toulouse) and of the FON for their excellent technical assistance.
- 8.Rodriguez-Nava V, Lebeaux D, Lortholary O, Boiron P (2013) Nocardia. In: Freney J, Renaud F, Leclercq R, Riegel P (eds) Précis de bactériologie clinique, 2nd edn. Eska, Paris, p 1764Google Scholar
- 12.Kohn AS, Conrad DA (2003) Recurrent fevers in a five-year-old boy with cystic fibrosis. Pediatr Infect Dis J 22(474):478–479Google Scholar
- 13.Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME (1994) Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The pulmozyme study group. N Engl J Med 331:637–642PubMedCrossRefGoogle Scholar
- 18.French Society for Microbiology (CASFM). Les recommandations du Comité de l’Antibiogramme de la Société Française de Microbiologie, 2013Google Scholar
- 19.Clinical and Laboratory Standars Institute (CLSI). Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard-second edition, 2011. Clinical and Laboratory Standards InstituteGoogle Scholar
- 24.Conville PS, Brown-Elliott BA, Wallace RJ Jr, Witebsky FG, Koziol D, Hall GS, Killian SB, Knapp CC, Warshauer D, Van T, Wengenack NL, Deml S, Woods GL (2012) Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol 50:1270–1280PubMedCentralPubMedCrossRefGoogle Scholar
- 28.Goodfellow M (1998) Nocardia and related genera. In: Balows A, Duerden BI (ed) Topley and Wilson’s microbiology and microbial infections, 9th edn. London, pp 463–489Google Scholar
- 35.Taj-Aldeen SJ, Deshmukh A, Doiphode S, Wahab AA, Allangawi M, Almuzrkchi A, Klaassen CH, Meis JF (2013) Molecular identification and susceptibility pattern of clinical Nocardia species: emergence of Nocardia crassostreae as an agent of invasive nocardiosis. Can J Infect Dis Med Microbiol 24:e33–e38PubMedCentralPubMedGoogle Scholar
- 36.Dasgupta B, Brown N, Rennie R, Sand C (2004). Presented at the Canadian association for microbiology and infectious diseases annual conference, Regina, Saskatchewan, Nov 7–10Google Scholar